Does soluble CD44 reflect the clinical behavior of human cancer?
Ristamäki
R
R
National Public Health Institute, Turku University, Finland.
Joensuu
H
H
Jalkanen
S
S
D014408:Biomarkers, Tumor; D002277:Carcinoma / Q000378:metabolism / Q000473:pathology; D002448:Cell Adhesion; D002465:Cell Movement; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D018960:Hyaluronan Receptors / Q000737:chemistry / Q000502:physiology*; D008223:Lymphoma / Q000378:metabolism / Q000473:pathology; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000737:chemistry / Q000502:physiology*; D009369:Neoplasms / Q000378:metabolism / Q000473:pathology*; D012995:Solubility
D014408:Biomarkers, Tumor; D006133:Growth Substances; D018960:Hyaluronan Receptors; D009363:Neoplasm Proteins